STOCK TITAN

DIH Appoints Dennis Streppa to DIH Holding US, Inc. Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

DIH Holding US (NASDAQ:DHAI), a global provider of advanced robotic rehabilitation devices, has appointed Dennis Streppa to its Board of Directors and as Audit Committee Chair. Streppa brings significant healthcare industry experience, having served as a global Chief Operations Officer with expertise in both public and private healthcare companies.

His background includes driving M&A value at Cardinal Health, leading an $800M manufacturing P&L, and executing multi-million-dollar private equity deals. The appointment expands DIH's board to five members, with three being independent, strengthening the company's governance structure.

DIH Holding US (NASDAQ:DHAI), fornitore globale di dispositivi avanzati per la riabilitazione robotica, ha nominato Dennis Streppa nel suo Consiglio di Amministrazione e come Presidente del Comitato di Revisione. Streppa porta con sé una vasta esperienza nel settore sanitario, avendo ricoperto il ruolo di Chief Operations Officer a livello globale in aziende sanitarie sia pubbliche che private.

Il suo percorso professionale include la gestione del valore nelle operazioni di M&A presso Cardinal Health, la responsabilità di un P&L produttivo da 800 milioni di dollari e la realizzazione di operazioni di private equity multimilionarie. Questa nomina porta a cinque membri il Consiglio di Amministrazione di DIH, di cui tre indipendenti, rafforzando così la struttura di governance dell’azienda.

DIH Holding US (NASDAQ:DHAI), proveedor global de dispositivos avanzados de rehabilitación robótica, ha nombrado a Dennis Streppa en su Junta Directiva y como Presidente del Comité de Auditoría. Streppa aporta una amplia experiencia en la industria sanitaria, habiendo desempeñado el cargo de Director de Operaciones global en empresas sanitarias tanto públicas como privadas.

Su trayectoria incluye impulsar el valor en fusiones y adquisiciones en Cardinal Health, liderar un P&L de fabricación de 800 millones de dólares y ejecutar acuerdos de capital privado multimillonarios. Este nombramiento amplía la junta de DIH a cinco miembros, de los cuales tres son independientes, fortaleciendo la estructura de gobierno de la empresa.

DIH Holding US (NASDAQ:DHAI)는 첨단 로봇 재활 장비의 글로벌 공급업체로서 Dennis Streppa를 이사회 및 감사위원회 위원장으로 임명했습니다. Streppa는 공공 및 민간 의료 회사 모두에서 글로벌 최고운영책임자(COO)로 근무한 풍부한 의료 산업 경험을 보유하고 있습니다.

그의 경력에는 Cardinal Health에서 M&A 가치를 창출하고, 8억 달러 규모의 제조 손익(P&L)을 관리하며, 수백만 달러 규모의 사모펀드 거래를 수행한 경험이 포함됩니다. 이번 임명으로 DIH 이사회는 5명으로 확대되었으며, 그 중 3명이 독립 이사로 회사의 거버넌스 구조가 강화되었습니다.

DIH Holding US (NASDAQ:DHAI), fournisseur mondial d'appareils de rééducation robotique avancés, a nommé Dennis Streppa au sein de son conseil d'administration ainsi que président du comité d'audit. Streppa apporte une expérience significative dans le secteur de la santé, ayant occupé le poste de directeur des opérations globales dans des entreprises de santé publiques et privées.

Son parcours inclut la création de valeur lors de fusions-acquisitions chez Cardinal Health, la gestion d'un P&L de fabrication de 800 millions de dollars et la réalisation de transactions de capital-investissement de plusieurs millions de dollars. Cette nomination porte à cinq membres le conseil d'administration de DIH, dont trois indépendants, renforçant ainsi la structure de gouvernance de l'entreprise.

DIH Holding US (NASDAQ:DHAI), ein weltweit führender Anbieter fortschrittlicher robotischer Rehabilitationsgeräte, hat Dennis Streppa in seinen Vorstand berufen und ihn zum Vorsitzenden des Prüfungsausschusses ernannt. Streppa bringt umfassende Erfahrung aus der Gesundheitsbranche mit, da er als globaler Chief Operations Officer sowohl in öffentlichen als auch privaten Gesundheitsunternehmen tätig war.

Sein Hintergrund umfasst die Steigerung des M&A-Werts bei Cardinal Health, die Leitung eines Fertigungs-P&L von 800 Millionen US-Dollar sowie die Durchführung von Private-Equity-Deals im Millionenbereich. Die Ernennung erweitert den Vorstand von DIH auf fünf Mitglieder, von denen drei unabhängig sind, und stärkt so die Unternehmensführung.

Positive
  • Addition of experienced healthcare executive with proven track record in M&A and operations
  • Strengthened corporate governance with majority independent board (3 out of 5 members)
  • Enhanced audit oversight with appointment of new Audit Committee Chair
Negative
  • None.

NORWELL, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Dennis Streppa to its Board of Directors and filling the Audit Committee Chair position.

Dennis Streppa is a seasoned global Chief Operations Officer and entrepreneur with expertise spanning public and private healthcare companies. He’s driven M&A value at Cardinal Health, led manufacturing P&L for an $800M business, tripled margins as an entrepreneur, and spearheaded multi-million-dollar private equity deals. He holds an MBA from Kellogg and specializes in business transformation, cross-functional leadership, and optimizing operational results.

CEO, Jason Chen, stated: “We are thrilled to welcome Dennis Streppa to our Board of Directors as Chair of the Audit Committee. Dennis brings a rare combination of operational rigor, strategic vision, and deep experience in both public and private healthcare companies. His track record in driving growth, overseeing complex integrations, and building accountable teams will be invaluable as we continue to scale and strengthen our governance.”

Mr. Streppa commented on the appointment: “I am truly honored to join the Board of Directors and serve as Chair of the Audit Committee. I look forward to working with this talented team to strengthen governance, drive accountability, and help create value for our stakeholders. I’m excited to contribute my operational and strategic experience in supporting DIH’s success.”

The Board of Directors now comprises five members, with three independent members, further strengthening the company’s commitment to strong governance.

About DIH Holding US, Inc.

DIH stands for the vision to “Deliver Inspiration & Health” to improve the daily lives of millions of people with disabilities and functional impairments through providing devices and solutions enabling intensive rehabilitation. DIH is a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Built through the mergers of global-leading niche technology providers, DIH is a transformative rehabilitation solutions provider and consolidator of a largely fragmented and manual-labor-driven industry.

Caution Regarding Forward-Looking Statements

This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH’s projected future results. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the ability of DIH to achieve its projected revenue, the failure of DIH realize the anticipated benefits of the recently-completed business combination and access to sources of additional debt or equity capital if needed. While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

Investor Contact
Louisa Smith
Investor.relations@dih.com


FAQ

Who is Dennis Streppa and what is his role at DIH Holding US (NASDAQ:DHAI)?

Dennis Streppa is a seasoned global Chief Operations Officer who has been appointed to DIH's Board of Directors and as Audit Committee Chair. He brings expertise from both public and private healthcare companies, including experience at Cardinal Health and managing an $800M manufacturing P&L.

How many members are now on DIH Holding's (NASDAQ:DHAI) Board of Directors?

DIH Holding's Board of Directors now comprises five members, with three being independent directors.

What is DIH Holding's (NASDAQ:DHAI) main business focus?

DIH Holding is a global provider of advanced robotic rehabilitation devices that incorporate visual stimulation for clinical research and functional rehabilitation of patients with walking impairments, balance issues, and impaired arm and hand functions.

What experience does Dennis Streppa bring to DIH Holding (NASDAQ:DHAI)?

Dennis Streppa brings expertise in M&A value creation, manufacturing operations, business transformation, and private equity deals. He holds an MBA from Kellogg and has experience in both public and private healthcare companies.
DIH Holdings US

NASDAQ:DHAI

DHAI Rankings

DHAI Latest News

DHAI Latest SEC Filings

DHAI Stock Data

12.73M
21.94M
50.42%
2.08%
0.49%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NORWELL